Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 193

1.

Analysis of the cost effectiveness of recombinant versus urinary follicle-stimulating hormone in in vitro fertilization/intracytoplasmic sperm injection programs in the United States.

Silverberg K, Daya S, Auray JP, Duru G, Ledger W, Wikland M, Bouzayen R, O'Brien M, Falk B, Beresniak A.

Fertil Steril. 2002 Jan;77(1):107-13.

PMID:
11779599
2.

Impact of urinary FSH price: a cost-effectiveness analysis of recombinant and urinary FSH in assisted reproduction techniques in the USA.

Silverberg K, Schertz J, Falk B, Beresniak A.

Reprod Biomed Online. 2002 Nov-Dec;5(3):265-9.

PMID:
12470524
3.

Recombinant versus urinary follicle-stimulating hormone in intrauterine insemination cycles: a prospective, randomized analysis of cost effectiveness.

Gerli S, Casini ML, Unfer V, Costabile L, Bini V, Di Renzo GC.

Fertil Steril. 2004 Sep;82(3):573-8.

PMID:
15374698
5.

[In vitro fertilization in France: economic aspects and influence of the gonadotropin choice (urinary vs. recombinant) on cost].

de Mouzon J, Allavena E, Schmitt C, Frappé M.

Gynecol Obstet Fertil. 2004 Jun;32(6):508-18. French.

PMID:
15217566
6.

Models of cost-effectiveness of recombinant FSH versus urinary FSH.

Al-Inany H, Afnan M.

Hum Reprod. 2002 Jun;17(6):1671-3; author reply 1673-4. No abstract available. Erratum in: Hum Reprod. 2002 Jul;17(7):1929..

PMID:
12042297
7.

Efficacy and safety of highly purified menotropin versus recombinant follicle-stimulating hormone in in vitro fertilization/intracytoplasmic sperm injection cycles: a randomized, comparative trial.

European and Israeli Study Group on Highly Purified Menotropin versus Recombinant Follicle-Stimulating Hormone.

Fertil Steril. 2002 Sep;78(3):520-8.

PMID:
12215327
8.
9.
10.
12.
13.
14.
15.

[Health economic consequences of the choice of follicle stimulating hormone alternatives in IVF treatment].

Poulsen PB, Højgaard A, Quartarolo JP.

Ugeskr Laeger. 2007 Apr 2;169(14):1313-7. Danish.

PMID:
17437694
16.

Comparison of two recombinant follicle-stimulating hormone preparations in in-vitro fertilization: a randomized clinical study.

Tulppala M, Aho M, Tuuri T, Vilska S, Foudila T, Hakala-Ala-Pietilä T, Moilanen J, Bützow T, Kaukoranta S, Söderström-Anttila V, Siegberg R, Suikkari AM, Hovatta O.

Hum Reprod. 1999 Nov;14(11):2709-15.

PMID:
10548606
17.
18.

Delivery rates following IVF treatment, using two recombinant FSH preparations for ovarian stimulation.

Harlin J, Aanesen A, Csemiczky G, Wramsby H, Fried G.

Hum Reprod. 2002 Feb;17(2):304-9.

PMID:
11821268

Supplemental Content

Support Center